V2M PHARMA LIMITED

Company Registration Number:
11490199 (England and Wales)

Unaudited abridged accounts for the year ended 29 November 2022

Period of accounts

Start date: 01 December 2021

End date: 29 November 2022

V2M PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 29 November 2022

Balance sheet
Notes

V2M PHARMA LIMITED

Balance sheet

As at 29 November 2022


Notes

2022

2021


£

£
Called up share capital not paid: 0 0
Fixed assets
Investments: 3 0 50
Total fixed assets: 0 50
Current assets
Stocks: 343,756
Debtors:   94,862 78,397
Cash at bank and in hand: 4,494 288
Total current assets: 443,112 78,685
Creditors: amounts falling due within one year:   (266,168) (222,547)
Net current assets (liabilities): 176,944 (143,862)
Total assets less current liabilities: 176,944 (143,812)
Creditors: amounts falling due after more than one year:   (252,817) (45,719)
Total net assets (liabilities): (75,873) (189,531)
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: (76,873) (190,531)
Shareholders funds: (75,873) (189,531)

The notes form part of these financial statements

V2M PHARMA LIMITED

Balance sheet statements

For the year ending 29 November 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 September 2024
and signed on behalf of the board by:

Name: Hardeep Rai
Status: Director

The notes form part of these financial statements

V2M PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 29 November 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

V2M PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 29 November 2022

2. Employees

2022 2021
Average number of employees during the period 2 2

V2M PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 29 November 2022

3. Fixed investments

Fixed asse investments are stated at cost less provision for any permanent diminution in value.